Brain Derived Basic Fibroblast Growth Factor (1-24)
CAS No. 211362-85-5
Brain Derived Basic Fibroblast Growth Factor (1-24)( ——— )
Catalog No. M41155 CAS No. 211362-85-5
Brain Derived Basic Fibroblast Growth Factor (1-24) (FGF basic 1-24) is a synthetic peptide, shows anti-bacterial and anti-HBV activities. Brain Derived Basic Fibroblast Growth Factor (1-24) can be used in infection disease and immune disease research.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 157 | In Stock |
|
| 25MG | Get Quote | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBrain Derived Basic Fibroblast Growth Factor (1-24)
-
NoteResearch use only, not for human use.
-
Brief DescriptionBrain Derived Basic Fibroblast Growth Factor (1-24) (FGF basic 1-24) is a synthetic peptide, shows anti-bacterial and anti-HBV activities. Brain Derived Basic Fibroblast Growth Factor (1-24) can be used in infection disease and immune disease research.
-
DescriptionBrain Derived Basic Fibroblast Growth Factor (1-24) (FGF basic 1-24) is a synthetic peptide, shows anti-bacterial and anti-HBV activities. Brain Derived Basic Fibroblast Growth Factor (1-24) can be used in infection disease and immune disease research.
-
In VitroBrain Derived Basic Fibroblast Growth Factor (1-24) (10 μg/mL; 12 h) inhibits the growth of Streptococcus pneumoniae.Brain Derived Basic Fibroblast Growth Factor (1-24) (10 μg/mL; 6 d) inhibits HBV replication of HepG2-2.2.15 cells.Brain Derived Basic Fibroblast Growth Factor (1-24) (10 μg/mL; 22 h) inhibits the migration of human endothelial cell.Cell Viability Assay Cell Line:Streptococcus pneumoniae Concentration:10 μg/mL Incubation Time:12 hours Result:Inhibited by 100% the growth of Streptococcus pneumoniae.RT-PCR Cell Line:HepG2-2.2.15 cells Concentration:10 μg/mL Incubation Time:6 days Result:Inhibited by 31.4% HBV replication as compared to the virus control infection.Cell Migration Assay Cell Line:Human endothelial cells (HUVEC)Concentration:10 μg/mL Incubation Time:22 hours Result:Inhibited by 17% the migration of human endothelial cells
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number211362-85-5
-
Formula Weight2553.86
-
Molecular FormulaC118H173N31O33
-
Purity>98% (HPLC)
-
SolubilityDMSO : 100 mg/mL (39.16 mM; ultraphonic; )
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Trans-caffeic acid
Trans-caffeic acid stearyl ester is posited to inhibit melanogenesis signaling while suppressing cAMP levels and, subsequently, MC1R, MITF, tyrosinase, TRP-2 and TRP-1 down-regulation, resulting in the suppression of tyrosinase activity, DOPA oxidase activity and melanin synthesis.
-
Microgrewiapine A
Microgrewiapine A is a selective cytotoxic agent for colon cancer cells over normal colon cells and to exhibit nicotinic receptor antagonistic activity for both the hα3β4 and hα4β2 receptor subtypes.
-
Riluzole hydrochlori...
Riluzole hydrochloride (PK 26124 hydrochloride) is an anticonvulsant compound belonging to the family of sodium channel blockers that inhibits GABA uptake.
Cart
sales@molnova.com